Cancer Prevention Initiative Inc

Organization Overview

Cancer Prevention Initiative Inc is located in Dallas, TX. The organization was established in 2015. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cancer Prevention Initiative Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2021, Cancer Prevention Initiative Inc generated $151.0 in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (70.6%) each year. All expenses for the organization totaled $308.0k during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

CANCER PREVENTION INITIATIVE, INC. (CPI) IS A NONPROFIT CORPORATION WHOSE MISSION IS TO ACCELERATE THE DISCOVERY AND DEVELOPMENT OF NEW MEDICINES THAT PREVENT CANCER.

Describe the Organization's Program Activity:

Part 3 - Line 4a

IN 2021, THE CANCER PREVENTION INITIATIVE (CPI) PROGRAMS HAVE PROGRESSED AND CPI CONTINUES TO GROW AND DEVELOP. CPI'S RESEARCH GRANT RECIPIENTS HAVE CONTINUED TO ADVANCE US TOWARDS UNDERSTANDING AND PREVENTING INHERITED CANCERS. A NEWLY FUNDED PROJECT WITH CLEVELAND CLINIC SEEKS TO IDENTIFY PROTEINS UNIQUELY AND HIGHLY EXPRESSED IN BREAST CANCER OF BRCA1 MUTATION CARRIERS. IDENTIFICATION OF THESE UNIQUE PROTEINS IS AN IMPORTANT LINK FOR DEVELOPING PREVENTATIVE VACCINES. ALSO NEWLY FUNDED IS A PROJECT WITH MEMORIAL SLOAN KETTERING CANCER CENTER TO GENERATE A ROBUST CELLULAR ASSAY THAT WOULD ALLOW FOR THE SCREENING OF HUNDREDS OF COMPOUNDS TO IDENTIFY DETERMINANTS OF LOSS OF HETEROZYGOSITY (LOH) OF BRCA GENES. LOH IS A MAJOR DRIVER IN CANCER INITIATION, AND DISCOVERY OF COMPOUNDS THAT CAUSE LOH CAN BE KEY FOR PREVENTION DISCOVERIES. ONGOING PROJECTS INCLUDE HARVARD'S BETH ISRAEL DEACONESS MEDICAL CENTER WHERE THEY ARE WORKING TO IDENTIFY CANCER RISK PREDICTORS IN THE REPRODUCTIVE EPITHELIUM IN BRCA MUTATION CARRIERS. A PROJECT AT CITY OF HOPE IS PROGRESSING TO REPURPOSE A SAFE, FDA APPROVED ANTI-PARASITIC DRUG THAT HAS GREAT PROMISE FOR REDUCING BREAST CANCER GROWTH. REPURPOSING DRUGS IS A SAFE WAY TO BRING THERAPIES TO PATIENTS QUICKLY. RELATED TO THIS IS A NEED FOR WAYS TO EVALUATE KNOWN DRUGS FOR NEW PURPOSES. A TEAM AT THE UNIVERSITY OF TORONTO IS DEVELOPING A TEST TO SCREEN FOR DRUGS THAT CAN RESTORE NORMAL BRCA1 FUNCTION TO BRCA1 DEFICIENT CELLS. AN INTERNATIONAL COLLABORATION HAS CO-DEVELOPED A CANDIDATE VACCINE FOR THE PREVENTION OF TRIPLE NEGATIVE BREAST CANCERS IN PATIENTS WHO HAVE INHERITED A BRCA1 MUTATION. NEW GRANTS WERE MADE IN 2021 TOTALED $480,000. THIS AMOUNT IS OFFSET BY THE RETURN OF $264,764 FROM A 2017 GRANT WHERE THE GRANTEE WAS NOT ABLE TO COMPLETE THEIR CONTRACTED PROJECT. THE GRANT EXPENSES FOR 2021 ARE $480,000 - 264,764 = $215,236.


EDUCATION AND COMMUNITY ENGAGEMENT PROGRAMS: AS WE MOVE CLOSER TO OUR GOAL OF ERADICATING ALL CANCERS THROUGH PREVENTATIVE MEDICINES, WE BELIEVE THAT EDUCATING THE PUBLIC AND RAISING AWARENESS ABOUT INHERITED CANCER SYNDROMES WILL INSPIRE MORE INDIVIDUALS TO TAKE PROACTIVE, LIFE-SAVING PREVENTIVE MEASURES. ONE OF THE GOALS IS TO ENHANCE THE SCIENTIFIC REACH OF THE ORGANIZATION AND RAISE AWARENESS ON CANCER PREVENTION TO A BROADER AUDIENCE OF PATIENTS, ADVOCATES AND DONORS. THUS, REGULAR UPDATES ON SCIENTIFIC AND MEDICAL RESEARCH ADVANCES, RECENT CLINICAL TRIALS, AND INTERVIEWS WITH EXPERTS IN CANCER PREVENTION ARE PUBLISHED ON WEB-BASED PLATFORMS.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$135
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$135
Total Program Service Revenue$0
Investment income $16
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $151

Grants Awarded

Over the last fiscal year, Cancer Prevention Initiative Inc has awarded $480,000 in support to 3 organizations.

Grant RecipientAmount

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

Org PageRecipient Profile

Dallas, TX

PURPOSE: Scientific and administrative oversight of all Cancer Prevention Initiative programs.

$180,000

CLEVELAND CLINIC FOUNDATION

Org PageRecipient Profile

Independence, OH

PURPOSE: The objective of this project is to identify proteins uniquely and highly expressed in breast cancer of BRCA1 mutation carriers. Identification of these proteins can be key to developing preventative vaccines.

$150,000

MEMORIAL SLOAN KETTERING CANCER CENTER

Org PageRecipient Profile

New York, NY

PURPOSE: The objective of this project is to generate a robust cellular assay that would allow for the screening of hundreds of compounds to identify determinants of Loss of Heterozygosity (LoH) of BRCA genes. LoH is a major driver in cancer initiation.

$150,000
View Grant Profile

Grants Recieved

Over the last fiscal year, we have identified 1 grants that Cancer Prevention Initiative Inc has recieved totaling $250,000.

Awarding OrganizationAmount
Greater Horizons

Kansas City, MO

PURPOSE: Medical Research

$250,000
View Grant Recipient Profile

Create an account to unlock the data you need.

or